US Broker Ratings

Prothena Corporation plc (PRTA) Stock Analysis: Unveiling a 151.76% Potential Upside in Biotechnology

Prothena Corporation plc (NASDAQ: PRTA) is currently captivating the attention of investors in the biotechnology sector with its significant potential for upside. Based in Dublin, Ireland,..

MBX Biosciences, Inc. (MBX) Stock Analysis: An 88.72% Potential Upside Fuels Investor Optimism

MBX Biosciences, Inc. (MBX) stands at the forefront of the biotechnology industry with its focus on precision peptide therapies, aiming to revolutionize treatments for endocrine and..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling a 112% Potential Upside for Investors in Biotech

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing the attention of investors in the biotechnology sector with a striking potential upside of 112.06%. With its current stock..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking a Potential 725% Upside Amidst Biotech Challenges

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology firm specializing in treatments for serious retinal diseases, presents a remarkable opportunity for investors despite recent financial challenges. With a..

MeiraGTx Holdings plc (MGTX) Investor Outlook: Exploring a Potential 180% Upside in Gene Therapy Innovations

For investors with a keen eye on the biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) represents an intriguing opportunity. This clinical-stage gene therapy company, headquartered in..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Unlocking a 109.83% Potential Upside in Biotech

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company based in Menlo Park, California, presents an intriguing investment opportunity within the dynamic biotechnology sector. Specializing in..

Celcuity Inc. (CELC) Stock Analysis: Uncovering a 160% Upside Potential in Biotechnology

For investors with an appetite for high-risk, high-reward opportunities, Celcuity Inc. (NASDAQ: CELC) might just be the stock to consider. With a compelling potential upside of..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 269.74% Upside in Biotech Innovation

For investors with a keen eye on the biotechnology sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing opportunity. With its groundbreaking work in bioengineered human tissues,..

Abivax SA (ABVX) Stock Report: Strong Buy Ratings Signal 77% Potential Upside in Biotech Innovator

Abivax SA (ABVX), a Paris-based biotechnology firm specializing in therapeutics for chronic inflammatory diseases, is capturing investor attention with a compelling 77.08% potential upside, as indicated..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 149% Potential Upside in Precision Medicine

For investors seeking opportunities in the healthcare sector, particularly within the burgeoning field of biotechnology, Tyra Biosciences, Inc. (NASDAQ: TYRA) presents a compelling case. As a..

Precigen, Inc. (PGEN) Stock Analysis: Unpacking the 89.72% Potential Upside for Biotech Investors

For those venturing into the world of biotechnology investments, Precigen, Inc. (NASDAQ: PGEN) presents an intriguing opportunity that combines cutting-edge gene and cell therapy innovations with..

Myriad Genetics (MYGN) Investor Outlook: Navigating Challenges in the Diagnostics & Research Sector

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is catching investor attention with its innovative molecular diagnostic tests...

AbCellera Biologics Inc. (ABCL) Stock Analysis: Potential 32.64% Upside Attracts Investors Amid Challenging Metrics

AbCellera Biologics Inc. (NASDAQ: ABCL), a biotechnology firm based in Vancouver, Canada, is making waves in the healthcare sector with its focus on developing antibody-based medicines...

REGENXBIO Inc. (RGNX) Stock Analysis: Unveiling a 229% Potential Upside in Biotech Investing

Investors with an appetite for high-risk, high-reward opportunities may find REGENXBIO Inc. (NASDAQ: RGNX) an intriguing prospect within the biotechnology sector. With a market capitalization of..

Cel-Sci Corporation (CVM): Analyst Ratings Signal a 618% Upside in Biotech Play

For investors keeping a keen eye on the biotechnology sector, Cel-Sci Corporation (NASDAQ: CVM) presents a fascinating opportunity. As a clinical-stage biotechnology firm, Cel-Sci is at..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 3.47% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, is facing a challenging yet potentially rewarding landscape. With a market cap of..

Claritev Corporation (CTEV) Stock Analysis: A 92.79% Potential Upside in the Healthcare Sector

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare sector, is drawing significant attention from investors due to its impressive potential upside of 92.79%. Despite..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Navigating Growth with a 20.61% Potential Upside

Investors seeking opportunities in the healthcare sector may find OrthoPediatrics Corp. (NASDAQ: KIDS) an intriguing prospect, particularly given its focus on the niche but critical market..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring Its Strategic Positioning Amidst Market Stagnation

Investors interested in the biotechnology sector may find Theravance Biopharma, Inc. (NASDAQ: TBPH) to be an intriguing subject due to its strategic collaborations and niche product..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a 123.80% Upside Potential in Biotech

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical innovator, has been garnering significant attention within the biotechnology sector, largely due to its promising pipeline and the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds